Furthermore, HER2-overexpression has been linked to radioresistance and epithelial-to-mesenchymal transition in breast cancer stem cells [41, 42], which are crucial for tumor invasion, migration, and metastatic outgrowth [43]. Here, ERBB2 is linked to breast carcinoma.